Breaking Ground in HER2-Positive Metastatic Breast Cancer Treatment

This comprehensive book covers over 30 years of preclinical and clinical research on the treatment of HER2-positive metastatic breast cancer, providing a detailed overview of the significant improvements in prognosis and survival rates achieved through the development of medications targeting the HER2/neu receptor.

The book presents the most important scientific data in a concise manner, making it an invaluable resource for healthcare professionals and researchers in the field. Additionally, it highlights the importance of patient-centered care in this disease setting and offers new perspectives on improving treatment outcomes.

As a result of the groundbreaking research and advancements in medication, the prognosis and survival rates for patients with HER2-positive metastatic breast cancer have significantly improved. This book provides a comprehensive understanding of the current state of research and treatment options, making it an essential read for anyone involved in the diagnosis, treatment, and care of patients with this disease.

Key Features:

• Covers over 30 years of research on HER2-positive metastatic breast cancer treatment
• Presents the most important scientific data in a concise manner
• Highlights the importance of patient-centered care in this disease setting
• Offers new perspectives on improving treatment outcomes

Publication Details:

Publisher: UNI-MED Verlag AG

Publication Date: April 3, 2023

Language: German